Hired someone new and exciting? Promoted a rising star? Finally solved that hard-to-fill spot? Share the news with us and we’ll share with it others. That’s right. Send us your announcements and we’ll find a home for them. Don’t be shy. Everyone wants to know who is coming and going, especially with all the layoffs. Despite the downsizing, there is movement. Here are some of the latest changes. Recognize anyone?

And here is our regular feature. Send us a photo and we will spotlight a different person each week. This time around, we note that Acetylon Pharmaceuticals hired Catherine Wheeler as vp of clinical development. Previously, she was site head, translational medicine, oncology at Hoffmann-La Roche. Before that, she worked for AstraZeneca.

Patheon added Michel Lagarde to its board;
AstraZeneca named Lisa Anson UK country president;
Fate Therapeutics named William Rastetter as chairman and ceo;
Novocure hired Peter Melnyk as chief commercial officer;
Novocure hired Angela Davies as exec vp, head of clinical development;
Novocure hired Laura Benson as vp medical affairs;
Thoratec added William Hawkins to its board;
Pfizer added Marc Tesser-Lavigne to its board;
PPD ceo Raymond Hill has left the building;
Johnson & Johnson named Michael Sneed vp of global corporate affairs;
ABPI named Deepak Khanna as president elect;
Kane Biotech named Mark Matthewson as cfo;
Pfizer elected Ian Read as chairman;
EKR Therapeutics added Robert Whitehead and Joseph Mahady to its board;
Essentialis added Richard Pasternack to its board;
Eli Lilly added Katherine Baicker to its board;
Mylan Laboratories hired John Thievon as president of Dey Pharma;
Zyngenia promoted David Hilbert to chief scientific officer;
Zyngenia named Daniel Menichella as chief business officer;

Ladder shot thx to Robert CB on Flickr Creative Commons